# Amgen Inc: Form 8-K, filed Feb 19, 2026

- Company: [Amgen Inc](/companies/amgn.md) (CIK 318154)
- Form: 8-K
- Filed: 2026-02-19
- Accepted by EDGAR: Feb 19, 2026, 16:27 ET
- Period: 2026-02-17
- Accession: 0001193125-26-059490
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/318154/000119312526059490/d106293d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/318154/000119312526059490/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/318154/000119312526059490/d106293d8k.htm

Filed Feb 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-059490. Last ingested by Listed: Oct 27, 2026, 19:36 ET. No prices; not investment advice.